Yield10 Bioscience Inc YTENQ

$0.00 0.00 (—)

Valuation

Market cap
0
Revenue TTM
$60,000
Net income TTM
$-14,460,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-24,100.00%
Debt to equity
0.00

Trading

Volume
1,100
Avg volume
2,458
Day's range
$0.00 – $0.00
Shares out
734,000
Stochastic %K
0%
Beta
-0.30
Analysts
—
Price target
$11.99

Price

Company profile

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD)...

Show more

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on October 14, 2025.

Industry
Agricultural Inputs
Sector
Basic Materials
Phone
617 583 1700
Website
https://www.yield10bio.com
Address
19 Presidential Way, Woburn, United States

Latest news

No headlines yet.